The nurse, who had no previous history of allergies, is now in a stable condition after receiving immediate treatment at the hospital in Juneau, Alaska, where she was given the COVID-19 vaccination. A serious allergic reaction has emerged within minutes of receiving the Pfizer/BioNTech injection, as was reported by Еxpress with a reference to the New York Times report.
According to the New York Times, a middle-aged woman is understood to have suffered a severe anaphylactic reaction that began 10 minutes after receiving the vaccine. A rash quickly spread across her face and torso and her breathing and heart rate became rapid before she was rushed into the emergency room. According to the hospital director Lindy Jones, the women’s symptoms eased when she was given a dose of the allergy treatment epinephrine. Given the circumstances, the US launched an investigation.
Pfizer said the vaccine comes with a clear warning that appropriate medical treatment and supervision should always be readily available in case of anaphylaxis but it would update the labeling language for the vaccine if needed.
The allergic reaction to COVID-19 jab in Alaska was similar to two cases of adverse reaction reported last week in Britain when two NHS workers both suffered anaphylactic reactions to the jab. Both have now fully recovered. The UK medical regulators noticed, that anyone with a history of anaphylaxis, or severe allergic reactions to medicine or food, should not get the Pfizer-BioNTech COVID-19 vaccine. On the contrary, US Food and Drug Administration said that most Americans with allergies should be safe to receive the vaccine and only people who have previously had severe allergic reactions to vaccines or ingredients in this particular vaccine should avoid getting the jab
According to “Apostrophe”, the US began its Covid-19 vaccine roll-out on Monday, November 14, after the Pfizer-BioNTech drug was given emergency-use authorization last week.